Imxia 5 Solution contains Minoxidil 5% w/v, a potent vasodilator primarily indicated for the treatment of androgenetic alopecia in both men and women. Minoxidil promotes hair regrowth by enhancing follicular size and prolonging the anagen phase of the hair cycle, thereby increasing hair density and thickness. The topical solution is applied directly to the scalp, allowing localized absorption and minimizing systemic exposure. Imxia 5 Solution is typically used twice daily on the affected scalp areas, with consistent application necessary to achieve optimal therapeutic outcomes. Clinical studies have demonstrated significant improvement in hair count and scalp coverage after several months of continuous use. Common adverse effects may include mild scalp irritation, itching, dryness, or erythema, which are generally transient and resolve with continued use or discontinuation. Patients with hypersensitivity to Minoxidil or any formulation components should avoid this medication. Caution is advised in individuals with cardiovascular conditions due to Minoxidil’s vasodilatory properties, although systemic absorption from topical use is minimal. Imxia 5 Solution should not be applied to broken or inflamed skin. It is important to maintain regular follow-up to assess efficacy and tolerability. Discontinuation of treatment may result in the reversal of hair regrowth benefits.